We launch big ideas

We partner with inventors, universities, and entrepreneurs to launch big ideas. A holistic approach to public venture capital in which everyone involved does better.

Our Public Venture Capital Process
Cue Biopharma Inc

Selectively modulating T-cells to fight cancer.

 
Cue Biopharma (NASDAQ: CUE), a clinical-stage biopharmaceutical company, is engineering a novel class of injectable biologics to selectively engage and modulate targeted T-cells directly within the body to transform the treatment of cancer, infectious diseases, and autoimmune diseases.

cue-biopharma-image
cue-biopharma-image
Provention Bio

Intercepting and preventing immune-related diseases

Provention Bio (NASDAQ: PRVB), is a biopharmaceutical company focused on advancing the development of investigational therapies that may intercept and prevent debilitating and life-threating immune-mediated diseases.

cue-biopharma-image
Pulse Biosciences

Delivering nanosecond pulses of energy to non-thermal cells

Pulse Biosciences (NASDAQ: PLSE), is a novel bioelectric medicine company committed to health innovation that has the potential to improve and extend the lives of patients.

cue-biopharma-image

Potential Spin-Outs — Companies in Development

PatentVest Logo